208 related articles for article (PubMed ID: 29526568)
1. E2F1 promotes hepatic gluconeogenesis and contributes to hyperglycemia during diabetes.
Giralt A; Denechaud PD; Lopez-Mejia IC; Delacuisine B; Blanchet E; Bonner C; Pattou F; Annicotte JS; Fajas L
Mol Metab; 2018 May; 11():104-112. PubMed ID: 29526568
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis.
Goyal N; Tiwary S; Kesharwani D; Datta M
J Mol Med (Berl); 2019 Jan; 97(1):115-126. PubMed ID: 30465059
[TBL] [Abstract][Full Text] [Related]
3. NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway.
Yang W; Wang J; Chen Z; Chen J; Meng Y; Chen L; Chang Y; Geng B; Sun L; Dou L; Li J; Guan Y; Cui Q; Yang J
Diabetes; 2017 Jul; 66(7):1819-1832. PubMed ID: 28411267
[TBL] [Abstract][Full Text] [Related]
4. DR-region of Na
Sun HJ; Cao L; Zhu MY; Wu ZY; Shen CY; Nie XW; Bian JS
Theranostics; 2020; 10(14):6149-6166. PubMed ID: 32483445
[TBL] [Abstract][Full Text] [Related]
5. Hepatic ZBTB22 promotes hyperglycemia and insulin resistance via PEPCK1-driven gluconeogenesis.
Liu N; Yang X; Guo J; Zhang L; Huang S; Chen J; Huang J; Chen Y; Cui T; Zheng Y; Li T; Tang K; Zhong Y; Duan S; Yu L; Tang Y; Zheng D; Pan H; Gao Y
EMBO Rep; 2023 Jun; 24(6):e56390. PubMed ID: 37154299
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis.
Wang J; Yang W; Chen Z; Chen J; Meng Y; Feng B; Sun L; Dou L; Li J; Cui Q; Yang J
Diabetes; 2018 Apr; 67(4):581-593. PubMed ID: 29382663
[TBL] [Abstract][Full Text] [Related]
7. Suppressor of cytokine signalling-2 controls hepatic gluconeogenesis and hyperglycemia by modulating JAK2/STAT5 signalling pathway.
Zhang X; Zhuang Y; Qin T; Chang M; Ji X; Wang N; Zhang Z; Zhou H; Wang Q; Li JZ
Metabolism; 2021 Sep; 122():154823. PubMed ID: 34197875
[TBL] [Abstract][Full Text] [Related]
8. TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.
Liu C; Zheng Y; Hu S; Liang X; Li Y; Yu Z; Liu Y; Bian Y; Man Y; Zhao S; Liu X; Liu H; Huang T; Ma J; Chen ZJ; Zhao H; Zhang Y
Metabolism; 2024 Mar; 152():155766. PubMed ID: 38145825
[TBL] [Abstract][Full Text] [Related]
9. The long non-coding RNA Gm10768 activates hepatic gluconeogenesis by sequestering microRNA-214 in mice.
Cui X; Tan J; Shi Y; Sun C; Li Y; Ji C; Wu J; Zhang Z; Chen S; Guo X; Liu C
J Biol Chem; 2018 Mar; 293(11):4097-4109. PubMed ID: 29363576
[TBL] [Abstract][Full Text] [Related]
10. Novel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes.
Saberi M; Bjelica D; Schenk S; Imamura T; Bandyopadhyay G; Li P; Jadhar V; Vargeese C; Wang W; Bowman K; Zhang Y; Polisky B; Olefsky JM
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1137-46. PubMed ID: 19706791
[TBL] [Abstract][Full Text] [Related]
11. Upregulated TGF-β1 contributes to hyperglycaemia in type 2 diabetes by potentiating glucagon signalling.
Xiao Y; Wang Y; Ryu J; Liu W; Zou H; Zhang R; Yan Y; Dai Z; Zhang D; Sun LZ; Liu F; Zhou Z; Dong LQ
Diabetologia; 2023 Jun; 66(6):1142-1155. PubMed ID: 36917279
[TBL] [Abstract][Full Text] [Related]
12. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
13. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
[TBL] [Abstract][Full Text] [Related]
14. A critical role for hepatic protein arginine methyltransferase 1 isoform 2 in glycemic control.
Ma Y; Liu S; Jun H; Wang J; Fan X; Li G; Yin L; Rui L; Weinman SA; Gong J; Wu J
FASEB J; 2020 Nov; 34(11):14863-14877. PubMed ID: 32918517
[TBL] [Abstract][Full Text] [Related]
15. FoxO6 integrates insulin signaling with gluconeogenesis in the liver.
Kim DH; Perdomo G; Zhang T; Slusher S; Lee S; Phillips BE; Fan Y; Giannoukakis N; Gramignoli R; Strom S; Ringquist S; Dong HH
Diabetes; 2011 Nov; 60(11):2763-74. PubMed ID: 21940782
[TBL] [Abstract][Full Text] [Related]
16. Micro-RNA-27a/b negatively regulates hepatic gluconeogenesis by targeting FOXO1.
Wang S; Ai H; Liu L; Zhang X; Gao F; Zheng L; Yi J; Sun L; Yu C; Zhao H; Li Y
Am J Physiol Endocrinol Metab; 2019 Nov; 317(5):E911-E924. PubMed ID: 31526292
[TBL] [Abstract][Full Text] [Related]
17. Sam68 promotes hepatic gluconeogenesis via CRTC2.
Qiao A; Zhou J; Xu S; Ma W; Boriboun C; Kim T; Yan B; Deng J; Yang L; Zhang E; Song Y; Ma YC; Richard S; Zhang C; Qiu H; Habegger KM; Zhang J; Qin G
Nat Commun; 2021 Jun; 12(1):3340. PubMed ID: 34099657
[TBL] [Abstract][Full Text] [Related]
18. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
[TBL] [Abstract][Full Text] [Related]
19. Involvement of KLF11 in hepatic glucose metabolism in mice via suppressing of PEPCK-C expression.
Zhang H; Chen Q; Jiao T; Cui A; Sun X; Fang W; Xie L; Liu Y; Fang F; Chang Y
PLoS One; 2014; 9(2):e89552. PubMed ID: 24586865
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity.
Qiao A; Ma W; Jiang Y; Han C; Yan B; Zhou J; Qin G
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
